Y. Koc Et Al. , "A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia," HEMATOLOGICAL ONCOLOGY , vol.22, no.2, pp.43-53, 2004
Koc, Y. Et Al. 2004. A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. HEMATOLOGICAL ONCOLOGY , vol.22, no.2 , 43-53.
Koc, Y., Oyan, B., Kars, A., Tekuzman, G., Canpinar, H., & Kansu, E., (2004). A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. HEMATOLOGICAL ONCOLOGY , vol.22, no.2, 43-53.
Koc, Y Et Al. "A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia," HEMATOLOGICAL ONCOLOGY , vol.22, no.2, 43-53, 2004
Koc, Y Et Al. "A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia." HEMATOLOGICAL ONCOLOGY , vol.22, no.2, pp.43-53, 2004
Koc, Y. Et Al. (2004) . "A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia." HEMATOLOGICAL ONCOLOGY , vol.22, no.2, pp.43-53.
@article{article, author={Y Koc Et Al. }, title={A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia}, journal={HEMATOLOGICAL ONCOLOGY}, year=2004, pages={43-53} }